Physician profile
Melinda Smith
NPI 1033221635
$1,946.18
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2020: $268 · 2021: $298 · 2022: $495 · 2023: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $326.91 | 2019-2023 | Lo Loestrin Fe, Orilissa, Liletta |
| Allergan, INC. | $196.59 | 2019 | |
| Myovant Sciences INC. | $146.08 | 2021-2022 | |
| Astellas Pharma US INC | $146.07 | 2020-2023 | Veozah, Myrbetriq |
| Amgen INC. | $135.00 | 2019-2021 | |
| Agile Therapeutics, INC. | $125.74 | 2021-2023 | Twirla |
| Therapeuticsmd, INC. | $122.42 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $103.41 | 2023 | Myfembree |
| Pfizer INC. | $101.26 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $97.36 | 2021-2023 | |
| Exeltis, USA INC. | $96.10 | 2020-2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $57.90 | 2021-2023 | |
| Hologic Sales and Service, LLC | $51.16 | 2019-2023 | Thinprep 2000 Processor |
| Evofem Biosciences, INC. | $51.00 | 2021-2022 | |
| Duchesnay USA Incorporated | $48.29 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $47.25 | 2019 | |
| Avion Pharmaceuticals | $33.83 | 2022 | |
| Mylan Pharmaceuticals INC. | $33.20 | 2020-2022 | |
| Lupin INC. | $13.56 | 2020 | |
| Daiichi Sankyo INC. | $13.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melinda Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.